William John Scheessele
Chief Commercial Officer at Humacyte, Inc. (HUMA) since August 2021
William John Scheessele has filed 8 insider reports with the SEC since August 2021, as chief Commercial Officer at Humacyte, Inc. (HUMA). William John Scheessele made no open-market purchases or sales in the last 12 months. In the latest filing, on April 15, 2025, William John Scheessele bought 6,493 shares of Humacyte, Inc. (HUMA) for $9,999 at an average of $1.54.
- Filings
- 8
- Companies
- 1
- Bought on market
- $75.1K
- Sold on market
- None
Companies where William John Scheessele is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| Chief Commercial Officersince August 2021 | 22,018 | $75.1K | $3.41 | $0.4454-87% | Apr 15, 2025 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record. Price now: the latest daily close, against the average buy price.
Every filing
- Apr 14, 2025+$9,999HUMAChief Commercial Officer Scheessele William John bought $9,999 worth of shares (6,493 units at $1.54), increasing direct ownership by 42% to 22,018 unitsForm 4Open-market purchase
- Jan 21, 2025HUMASEC Form 4 filed by Chief Commercial Officer Scheessele William JohnForm 4Grant or award
- Dec 8, 2023HUMASEC Form 4 filed by Scheessele William JohnForm 4Grant or award
- Dec 13, 2022+$15.5KHUMASEC Form 4: Scheessele William John bought $15,450 worth of shares (5,000 units at $3.09), increasing direct ownership by 48% to 15,525 unitsForm 4Open-market purchase
- Dec 8, 2022HUMASEC Form 4 filed by Scheessele William JohnForm 4Grant or award
- May 24, 2022+$49.7KHUMASEC Form 4: Scheessele William John bought $49,678 worth of shares (10,525 units at $4.72)Form 4Open-market purchase
- Oct 13, 2021HUMASEC Form 4 filed by Scheessele William JohnForm 4Grant or award
- Aug 26, 2021HUMAWilliam John Scheessele became an insiderForm 3New insider
Compare William John Scheessele with
- William John Scheessele vs D Scott Coward1 shared
- William John Scheessele vs Keith Anthony Jones1 shared
- William John Scheessele vs Susan Richards Windham-Bannister1 shared
- William John Scheessele vs Michael T. Constantino1 shared
- William John Scheessele vs Max N. Wallace1 shared
- William John Scheessele vs Laura E Niklason1 shared
Other insiders at the same companies
- Paul Brian KuznikHUMA
- D Scott CowardHUMA
- Keith Anthony JonesHUMA
- Susan Richards Windham-BannisterHUMA
- Michael T. ConstantinoHUMA
- Max N. WallaceHUMA
- Laura E NiklasonHUMA
- Kathleen SebeliusHUMA
- Charles Bruce GreenHUMA
- Diane SeimetzHUMA
- John Philip BamforthHUMA
- Emery N. BrownHUMA
- Brady W DouganHUMA
- Dale A. SanderHUMA
- Shamik J ParikhHUMA
- Fresenius Medical Care Holdings Inc /ny/HUMA
Questions about William John Scheessele
- What is William John Scheessele's role at Humacyte, Inc.?
- William John Scheessele reports to the SEC as chief Commercial Officer at Humacyte, Inc. (HUMA), according to the latest filing on April 15, 2025.
- How many shares does William John Scheessele own?
- After the latest filing that states it, William John Scheessele directly owned 22,018 shares of Humacyte, Inc. (HUMA). Shares held through trusts, funds or family members are reported separately and are not counted here.
- Has William John Scheessele bought or sold stock recently?
- The most recent open-market purchase was on April 14, 2025: bought 6,493 shares of Humacyte, Inc. (HUMA) for $9,999 at an average of $1.54.
- How do I get alerts when William John Scheessele files?
- Follow William John Scheessele on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.
From SEC Forms 3, 4, 5 and 144 filed by William John Scheessele (SEC CIK 0001879378). Totals count each trade once, skipping amendments whose original is on file, from Aug 27, 2021 on. View on SEC EDGAR · Get this as JSON